Shukra Pharmaceuticals Ltd

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
INCOME :
Sales Turnover	6.61	5.77	5.15	4.85	2.66
Other Income	0.04	0.11	0.07	0.19	1.12
Stock Adjustments	0.17	-0.07	-0.09	-0.11	-0.42
Total Income	6.82	5.81	5.13	4.93	3.36
EXPENDITURE :
Raw Materials	1.16	0.89	0.95	1.64	0.47
Excise Duty	0.95	0.4	0.01	0.03	0.06
Power and Fuel Cost	0.34	0.29	0.26	0.26	0.28
Other Manufacturing Expenses	0.06	0.09	0.41	0.06	0.07
Employee Cost	1.91	1.23	1.05	1.13	1.19
Selling and Administration Expenses	0.71	1.2	0.92	0.44	0.41
Miscellaneous Expenses	0	0	0	0.58	0
Less: Preoperative Expenditure Capitalised	0	0	0	0	0
Profit before Interest, Depreciation and Tax	1.69	1.72	1.53	0.8	0.87
Interest and Financial Charges	0	0.04	0.01	0	0
Profit before Depreciation and Tax	1.69	1.68	1.52	0.8	0.87
Depreciation	0.96	0.74	0.47	0.45	0.6
Profit Before Tax	0.72	0.95	1.06	0.35	0.27
Tax	0.26	0.42	0.56	0.23	0.14
Profit After Tax	0.46	0.53	0.5	0.12	0.13
Adjustment below Net Profit	0	0	0	0	0
P and L Balance brought forward	9.19	8.66	8.16	8.04	7.91
Appropriations	0	0	0	0	0
P and L Bal. carried down	9.65	9.19	8.66	8.16	8.04
Equity Dividend	0	0	0	0	0
Preference Dividend	0	0	0	0	0
Corporate Dividend Tax	0	0	0	0	0
Equity Dividend (%)	5	5	5	0	0
Earning Per Share (Rs.)	2.95	3.36	3.21	0.76	0.84
Book Value	98.2	95.86	93.1	89.89	89.13
Extraordinary Items	0	0	0	-0.19	0.27

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

INCOME :

Sales Turnover

6.61

5.77

5.15

4.85

2.66

Other Income

0.04

0.11

0.07

0.19

1.12

Stock Adjustments

0.17

-0.07

-0.09

-0.11

-0.42

Total Income

6.82

5.81

5.13

4.93

3.36

EXPENDITURE :

Raw Materials

1.16

0.89

0.95

1.64

0.47

Excise Duty

0.95

0.4

0.01

0.03

0.06

Power and Fuel Cost

0.34

0.29

0.26

0.28

Other Manufacturing Expenses

0.06

0.09

0.41

0.06

0.07

Employee Cost

1.91

1.23

1.05

1.13

1.19

Selling and Administration Expenses

0.71

1.2

0.92

0.44

0.41

Miscellaneous Expenses

0.58

Less: Preoperative Expenditure Capitalised

Profit before Interest, Depreciation and Tax

1.69

1.72

1.53

0.8

0.87

Interest and Financial Charges

0.04

0.01

Profit before Depreciation and Tax

1.69

1.68

1.52

0.8

0.87

Depreciation

0.96

0.74

0.47

0.45

0.6

Profit Before Tax

0.72

0.95

1.06

0.35

0.27

Tax

0.26

0.42

0.56

0.23

0.14

Profit After Tax

0.46

0.53

0.5

0.12

0.13

Adjustment below Net Profit

P and L Balance brought forward

9.19

8.66

8.16

8.04

7.91

Appropriations

P and L Bal. carried down

9.65

9.19

8.66

8.16

8.04

Equity Dividend

Preference Dividend

Corporate Dividend Tax

Equity Dividend (%)

Earning Per Share (Rs.)

2.95

3.36

3.21

0.76

0.84

Book Value

98.2

95.86

93.1

89.89

89.13

Extraordinary Items

-0.19

0.27

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
SOURCES OF FUNDS :
Share Capital	1.57	1.57	1.57	1.57	1.57
Reserves and Surplus	13.81	13.44	13.01	12.51	12.39
Total Shareholders Funds	15.38	15.01	14.58	14.08	13.96
Secured Loans	0	0	0	0	0
Unsecured Loans	6.06	3.58	0.04	0.04	1.2
Total Debt	6.06	3.58	0.04	0.04	1.2
Total Liabilities	21.44	18.59	14.62	14.12	15.16
APPLICATION OF FUNDS :
Gross Block	28.51	26.06	21.38	20.41	20.01
Less: Accum. Depreciation	12.9	11.94	11.2	10.74	10.29
Net Block	15.61	14.12	10.18	9.67	9.72
Capital Work in Progress	1.66	1.66	1.64	1.68	1.68
Investments	0.05	0.05	0.04	0.04	0.03
Current Assets, Loans and Advances
Inventories	0.27	0.14	0.32	0.44	1.35
Sundry Debtors	5.35	2.93	2.47	0.94	0.52
Cash and Bank Balance	0.25	0.06	0.52	1.74	0.59
Loans and Advances	5.21	5.14	3.77	2.76	4.41
Less: Current Liab. and Prov.
Current Liabilities	6.11	4.78	3.74	2.96	2.99
Provisions	0.85	0.73	0.58	0.21	0.17
Net Current Assets	4.12	2.76	2.76	2.71	3.71
Miscellaneous Expenses not w/o	0	0	0	0	0
Total Assets	21.44	18.59	14.62	14.1	15.14
Contingent Liabilities	0	0	0	0	0

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

SOURCES OF FUNDS :

Share Capital

1.57

Reserves and Surplus

13.81

13.44

13.01

12.51

12.39

Total Shareholders Funds

15.38

15.01

14.58

14.08

13.96

Secured Loans

Unsecured Loans

6.06

3.58

0.04

1.2

Total Debt

6.06

3.58

0.04

1.2

Total Liabilities

21.44

18.59

14.62

14.12

15.16

APPLICATION OF FUNDS :

Gross Block

28.51

26.06

21.38

20.41

20.01

Less: Accum. Depreciation

12.9

11.94

11.2

10.74

10.29

Net Block

15.61

14.12

10.18

9.67

9.72

Capital Work in Progress

1.66

1.64

1.68

Investments

0.05

0.04

0.03

Current Assets, Loans and Advances

Inventories

0.27

0.14

0.32

0.44

1.35

Sundry Debtors

5.35

2.93

2.47

0.94

0.52

Cash and Bank Balance

0.25

0.06

0.52

1.74

0.59

Loans and Advances

5.21

5.14

3.77

2.76

4.41

Less: Current Liab. and Prov.

Current Liabilities

6.11

4.78

3.74

2.96

2.99

Provisions

0.85

0.73

0.58

0.21

0.17

Net Current Assets

4.12

2.76

2.71

3.71

Miscellaneous Expenses not w/o

Total Assets

21.44

18.59

14.62

14.1

15.14

Contingent Liabilities

Shukra Pharmaceuticals Ltd

Enjoy Lifetime Free Delivery Trade